<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Coupon More | McLeod Hay | Aktivität</title>
	<link>https://coupon-more.com/members/clefwoolen1/activity/</link>
	<atom:link href="https://coupon-more.com/members/clefwoolen1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Aktivitäts-Feed für McLeod Hay.</description>
	<lastBuildDate>Thu, 30 Apr 2026 05:06:30 +0200</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>de</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5b38fcc99e0595e4f3f5e35d6d17a158</guid>
				<title>McLeod Hay postete ein Update: A heightened phrase of PVT1 ended up being noticed in the [&#133;]</title>
				<link>https://coupon-more.com/activity/p/68726/</link>
				<pubDate>Fri, 27 Sep 2024 16:56:52 +0200</pubDate>

									<content:encoded><![CDATA[<p>A heightened phrase of PVT1 ended up being noticed in the untreated PBMCs of CAD customers <a href="https://p53signals.com/index.php/in-car-air-particle-issue-coverage-throughout-ten-global-cities/" rel="nofollow ugc">azd1080 inhibitor</a> , compared to the NCAD team. The PVT1 was dramatically up-regulated after LPS therapy into the PBMCs of both groups. Plasma MMP-9 levels were found is higher in CAD patients than in the control people. The level of IL-10 and IL-22&hellip;<span class="activity-read-more" id="activity-read-more-68726"><a href="https://coupon-more.com/activity/p/68726/" rel="nofollow ugc">[Weiterlesen]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">af7a6c4608dd4554e2634307cea2fecf</guid>
				<title>McLeod Hay postete ein Update: © 2020 The Authors. Medical Case Reports published by John [&#133;]</title>
				<link>https://coupon-more.com/activity/p/68260/</link>
				<pubDate>Tue, 24 Sep 2024 16:27:54 +0200</pubDate>

									<content:encoded><![CDATA[<p>© 2020 The Authors. Medical Case Reports published by John Wiley &amp; Sons Ltd.This case suggests a mechanistic rationale when it comes to clinical effectiveness of intravenous immunoglobulins (IVIG) in managing CD40 ligand (CD40L) deficiency associated neutropenia since it is the first reported instance of free and cell-bound antineutrophil&hellip;<span class="activity-read-more" id="activity-read-more-68260"><a href="https://coupon-more.com/activity/p/68260/" rel="nofollow ugc">[Weiterlesen]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a06e8a882b428c479806cb7be8bc3764</guid>
				<title>McLeod Hay postete ein Update: Conclusions CTC could be served as a predictive and [&#133;]</title>
				<link>https://coupon-more.com/activity/p/67534/</link>
				<pubDate>Sat, 21 Sep 2024 15:58:12 +0200</pubDate>

									<content:encoded><![CDATA[<p>Conclusions CTC could be served as a predictive and prognostic element for SCLC, therefore the nomogram designs constructed by CTC and multiple medical variables can comprehensively anticipate the prognosis of SCLC clients and do threat stratification. © The author(s).Cadherin 13 (CDH13) is an atypical cadherin that exerts tumor-suppressive&hellip;<span class="activity-read-more" id="activity-read-more-67534"><a href="https://coupon-more.com/activity/p/67534/" rel="nofollow ugc">[Weiterlesen]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">407e058d170c648ff6a3dc24b7393ba4</guid>
				<title>McLeod Hay wurde ein Mitglied</title>
				<link>https://coupon-more.com/activity/p/66714/</link>
				<pubDate>Fri, 20 Sep 2024 11:30:05 +0200</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>